CINGAL

£231.00

CINGAL® is the first and only approved combination viscosupplement formulated to provide the benefit of a cross-linked Hyaluronic Acid (HA) and a fast acting steroid

The corticosteroid Triamcinolone Hexacetonide (TH) works quickly to reduce inflammation

  • CINGAL delivers a 59% improvement in WOMAC pain at week 1 relative to baseline (p = 0.008)
  • CINGAL delivers a 72% improvement in WOMAC pain at 26 relative to baseline (p = 0.0027)
  • CINGAL delivers an 89% responder rate in the OMERACT-OARSI Responder Index at 1 week
    (p = 0.01671)
  • CINGAL delivers a 92% responder rate in the OMERACT-OARSI Responder Index through
    26 weeks (p = 0.0100)Lightly crossed-linked HA

Cingal Brochure

Cingal Brochure

Intraarticular Injection of a Cross-Linked Sodium Hyaluronate

Intraarticular Injection of a Cross-Linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Trial

Single intra-articular injection

Single intra-articular injection of lightly cross-linked hyaluronic acid reduces knee pain in symptomatic knee osteoarthritis: a multicenter, double-blind, randomized, placebo-controlled trial

  • CINGAL contains sodium hyaluronate that is lightly cross-linked to increase residence time in the jointNon-Avian HA
    CINGAL is made from ultra pure, high molecular weight sodium hyaluronate produced by bacterial fermentationNo pseudoseptic reactions
    No pseudoseptic reactions associated with CINGAL have been reported worldwide

Product Enquiry